In this review, we summarize the current knowledge of the TGF-β signaling pathway in GI tumors, focusing on the main regulatory mechanisms beyond its activation and on the signaling interplay between TGF-β and tumor suppressors or promoters involved in the variety of cellular responses exerted by TGF-β during GI progression. Here, TGFB1 is linked to digestive system neoplasm.